'Lenalidomide dexamethasone' presentation slideshows

Moderator Neil Love, MD

702 views • 70 slides

Monoclonal Antibodies in Multiple M yeloma

Monoclonal Antibodies in Multiple M yeloma . Jessica P. Duda, PharmD, BCOP, CPP Hematology/Oncology Specialty Practice Pharmacist Wake Forest Baptist Health JDuda@wakehealth.edu. Objectives. Identify monoclonal antibodies approved for treatment of multiple myeloma

1.24k views • 30 slides

Myeloma and Transplant

Myeloma and Transplant. Sergio A Giralt, MD Chief, Adult Bone Marrow Transplant Service Division of Hematologic Oncology Department of Medicine Memorial Sloan-Kettering Cancer Center New York, New York. Tale of Two Cases. 56-year-old female with symptomatic myeloma Multiple lytic lesions

442 views • 20 slides

Richardson PG et al. Proc ASH 2012; Abstract 202.

A Phase 2 Study of Elotuzumab in Combination with Lenalidomide and Low-Dose Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: Updated Results. Richardson PG et al. Proc ASH 2012; Abstract 202. Background.

352 views • 10 slides